PYY and Other metabolic disease: GLP-1, GLP-2, and PYY lower glucose concentrations (Meier, 2012), intestinal permeability (Cani et al., 2009), cytokine and amylase release (Vona-Davis and McFadden, 2007), thereby improving metabolic disorders and inflammation during diabetes.